chartexchange

PMCB
PharmaCyte Biotech, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 2:40:09 PM EST
5.49USD+1.384%(+0.07)6,332
Loading…
Loading…
Healthcare
Biotechnology
HQ
Las Vegas, NV, USA
Previous Close
$5.42
Beta
-1.90
52-Week High
$8.17 2026-11-13
52-Week Low
$0.25 2026-11-11
SMA 50
$0.96
SMA 200
$0.76
Avg. Vol 10D
203,009
Avg. Vol 30D
136,737
Avg. Vol 90D
187,641
Relative Vol
0.05
565,034
529,945
1.9100%
1,798
Dec 17, 2026 (28d)
Jul 12, 2021 · 1-for-1500 (reverse)
Nov 13, 2026
PMCB Profile

pharmacyte biotech, inc., a clinical stage biotechnology company, focuses on developing and commercializing cellular therapies for cancer and diabetes in the united states. its cellular therapies are developed based on cell-in-a-box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable non-metastatic pancreatic cancer, as well as diabetes. the company is developing therapies for pancreatic and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the activation of cancer-killing drugs to the source of the cancer. it is also developing a therapy for type 1 diabetes and insulin-dependent type 2 diabetes; and therapies for cancer based on the constituents of the cannabis plant. pharmacyte biotech, inc. has a research agreement with the university of technology, sydney to create a version of melligen cells to treat diabetes; and a research agreeme

PMCB Performance
PeriodPriceDateChangeBeta
1W7.642026-11-12-28.38%5.886
1M0.342026-10-19+1499.41%-3.809
3M0.532026-08-19+927.42%-6.361
6M0.732026-05-19+647.27%-4.173
1Y0.712025-11-19+666.11%-1.900
2Y1.852024-11-19+195.68%—
5Y2.612021-11-19+109.58%0.262
PMCB Stock Summary

PharmaCyte Biotech, Inc. Common Stock (NASDAQ:PMCB) stock price today is $5.47, and today's volume is 6,332. PMCB is up 0.923% today. The 30 day average volume is 136,737. PMCB market cap is $3.09M with 565,034 shares outstanding.